Metastatic myxoid liposarcoma: Aggressive multimodality management [7]

Clinical Oncology

Volumn 17, Issue 2, 2005, Pages 130-

  Prestwich, Robin J ^a   Taylor, Roger E ^a   Grimer, Rob ^b  

^a Northern and Yorkshire Clinical Trials and Research Unit   (United Kingdom)

^b ROYAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; DOXORUBICIN; IFOSFAMIDE; VINCRISTINE;

ADULT; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER SURVIVAL; CASE REPORT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LETTER; LONG TERM CARE; LUNG METASTASIS; MALE; METASTASIS POTENTIAL; MORBIDITY; MULTIMODALITY CANCER THERAPY; MYXOSARCOMA; NECK METASTASIS; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; SOFT TISSUE METASTASIS; SPINAL CORD METASTASIS; THIGH; TUMOR BIOPSY;

ADULT; COMBINED MODALITY THERAPY; HUMANS; LIPOSARCOMA, MYXOID; MALE; SOFT TISSUE NEOPLASMS;

EID: 14644442945     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2004.12.002     Document Type: Letter

References (3)

1. G. Pitson P. Robinson D. Wilke et al., Radiation response: An additional unique signature of myxoid liposarcoma Int J Radiat Oncol Biol Phys 60 2004 522-526
2. H. Hatano A. Ogose T. Hotta et al., Treatment of myxoid liposarcoma by marginal or intralesional resection combined with radiotherapy Anticancer Res 23 2003 3045-3049
3. A.J. Spillane C. Fisher J.M. Thomas Myxoid liposarcoma: The frequency and natural history of nonpulmonary soft tissue metastases Ann Surg Oncol 6 1999 389-394